Domouchtsidou, A.; Beckmann, F.; Marenbach, B.; Mueller, S.P.; Best, J.; Herrmann, K.; Horn, P.A.; Barsegian, V.; Lindemann, M.
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival. Cancers 2023, 15, 4055.
https://doi.org/10.3390/cancers15164055
AMA Style
Domouchtsidou A, Beckmann F, Marenbach B, Mueller SP, Best J, Herrmann K, Horn PA, Barsegian V, Lindemann M.
In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival. Cancers. 2023; 15(16):4055.
https://doi.org/10.3390/cancers15164055
Chicago/Turabian Style
Domouchtsidou, Aglaia, Ferdinand Beckmann, Beate Marenbach, Stefan P. Mueller, Jan Best, Ken Herrmann, Peter A. Horn, Vahé Barsegian, and Monika Lindemann.
2023. "In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival" Cancers 15, no. 16: 4055.
https://doi.org/10.3390/cancers15164055
APA Style
Domouchtsidou, A., Beckmann, F., Marenbach, B., Mueller, S. P., Best, J., Herrmann, K., Horn, P. A., Barsegian, V., & Lindemann, M.
(2023). In Patients Treated by Selective Internal Radiotherapy, Cellular In Vitro Immune Function Is Predictive of Survival. Cancers, 15(16), 4055.
https://doi.org/10.3390/cancers15164055